Log In
person
Precigen Inc
PGEN
summarize
2 total product lines
calendar_month
Revenue as of 12/31/2023
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Biopharmaceuticals |
Pre-Revenue Pharmaceuticals
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
0.08M | 1.20% |
| Exemplar |
Genetically-Modified Research Animals
These companies breed genetically-modified research animals for pharmaceutical and biotech companies.
|
6.15M | 98.80% |
| keyboard_arrow_down |
Biopharmaceuticals
Pre-Revenue Pharmaceuticals
|
0.08M | 1.20% |
| keyboard_arrow_right |
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
||
| keyboard_arrow_down |
Exemplar
Genetically-Modified Research Animals
|
6.15M | 98.80% |
| keyboard_arrow_right |
These companies breed genetically-modified research animals for pharmaceutical and biotech companies.
|
||